| __timestamp | Intra-Cellular Therapies, Inc. | Protagonist Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 21226345 | 7459000 |
| Thursday, January 1, 2015 | 87718074 | 11831000 |
| Friday, January 1, 2016 | 93831530 | 25705000 |
| Sunday, January 1, 2017 | 79419009 | 46181000 |
| Monday, January 1, 2018 | 132166913 | 59497000 |
| Tuesday, January 1, 2019 | 89124838 | 65003000 |
| Wednesday, January 1, 2020 | 65782137 | 74506000 |
| Friday, January 1, 2021 | 88845513 | 126006000 |
| Saturday, January 1, 2022 | 134715000 | 126215000 |
| Sunday, January 1, 2023 | 180142000 | 120161000 |
Igniting the spark of knowledge
In the competitive landscape of biotechnology, research and development (R&D) spending is a critical indicator of a company's commitment to innovation. Over the past decade, Intra-Cellular Therapies, Inc. and Protagonist Therapeutics, Inc. have demonstrated significant investment in R&D, reflecting their dedication to advancing medical science.
From 2014 to 2023, Intra-Cellular Therapies, Inc. increased its R&D expenses by over 750%, peaking in 2023 with a substantial investment. Meanwhile, Protagonist Therapeutics, Inc. also showed a robust growth trajectory, with a notable 1,500% increase in R&D spending from 2014 to 2022. This trend underscores the dynamic nature of the biotech sector, where companies are racing to innovate and bring new therapies to market.
As these companies continue to invest heavily in R&D, the potential for groundbreaking treatments and therapies remains high, promising a future of medical advancements.
Who Prioritizes Innovation? R&D Spending Compared for Pfizer Inc. and Protagonist Therapeutics, Inc.
Sanofi vs Protagonist Therapeutics, Inc.: Strategic Focus on R&D Spending
Research and Development Investment: Zoetis Inc. vs Intra-Cellular Therapies, Inc.
Research and Development Expenses Breakdown: argenx SE vs Intra-Cellular Therapies, Inc.
Research and Development Investment: Genmab A/S vs Intra-Cellular Therapies, Inc.
R&D Spending Showdown: Incyte Corporation vs Protagonist Therapeutics, Inc.
R&D Spending Showdown: Intra-Cellular Therapies, Inc. vs Opthea Limited
R&D Spending Showdown: Intra-Cellular Therapies, Inc. vs Apellis Pharmaceuticals, Inc.
Research and Development Expenses Breakdown: Intra-Cellular Therapies, Inc. vs Amicus Therapeutics, Inc.
Intra-Cellular Therapies, Inc. or Celldex Therapeutics, Inc.: Who Invests More in Innovation?
Protagonist Therapeutics, Inc. vs BioCryst Pharmaceuticals, Inc.: Strategic Focus on R&D Spending
Protagonist Therapeutics, Inc. vs MiMedx Group, Inc.: Strategic Focus on R&D Spending